Toronto Dominion Bank Edwards Lifesciences Corp Transaction History

Toronto Dominion Bank

$61.6 Billion
Q3 2025

A detailed history of Toronto Dominion Bank transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Toronto Dominion Bank holds 215,945 shares of EW stock, worth $18.6 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

215,945

Previous 276,218 21.82%

Holding current value

$18.6 Million

Previous $21.6 Million 22.26%

% of portfolio

0.03%

Previous 0.04%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$73.75 - $81.83 $4.45 Million - $4.93 Million	-60,273 Reduced 21.82%	215,945 $16.8 Million
Q2 2025 Aug 14, 2025	BUY	$67.07 - $78.22 $859,233 - $1 Million	12,811 Added 4.86%	276,218 $21.6 Million
Q1 2025 May 15, 2025	SELL	$67.95 - $76.19 $3.66 Million - $4.11 Million	-53,919 Reduced 16.99%	263,407 $19.1 Million
Q4 2024 Feb 14, 2025	BUY	$64.54 - $75.92 $1.1 Million - $1.29 Million	17,046 Added 5.68%	317,326 $23.5 Million
Q3 2024 Nov 14, 2024	BUY	$59.7 - $93.78 $239,277 - $375,870	4,008 Added 1.35%	300,280 $19.8 Million

Q2 2024 Aug 14, 2024	SELL	$84.3 - $94.31 $5.1 Million - $5.71 Million	-60,504 Reduced 16.96%	296,272 $27.4 Million
Q1 2024 May 14, 2024	BUY	$72.54 - $95.56 $505,458 - $665,862	6,968 Added 1.99%	356,776 $34.1 Million
Q4 2023 Feb 13, 2024	BUY	$61.71 - $77.76 $1.74 Million - $2.2 Million	28,261 Added 8.79%	349,808 $26.7 Million
Q3 2023 Feb 14, 2024	SELL	$69.28 - $93.38 $757,992 - $1.02 Million	-10,941 Reduced 3.29%	321,547 $22.3 Million
Q3 2023 Nov 14, 2023	SELL	$69.28 - $93.38 $757,992 - $1.02 Million	-10,941 Reduced 3.29%	321,547 $22.3 Million
Q2 2023 Feb 14, 2024	SELL	$81.41 - $94.33 $1.41 Million - $1.63 Million	-17,320 Reduced 4.95%	332,488 $31.3 Million
Q2 2023 Aug 10, 2023	BUY	$81.41 - $94.33 $68,302 - $79,142	839 Added 0.25%	332,488 $31.3 Million
Q1 2023 May 11, 2023	SELL	$74.26 - $84.51 $5,495 - $6,253	-74 Reduced 0.02%	331,649 $27.4 Million
Q4 2022 Feb 07, 2023	BUY	$68.3 - $87.44 $3.81 Million - $4.88 Million	55,809 Added 20.23%	331,723 $24.7 Million
Q3 2022 Nov 09, 2022	SELL	$82.37 - $107.29 $3.62 Million - $4.72 Million	-44,003 Reduced 13.75%	275,914 $22.8 Million
Q2 2022 Aug 11, 2022	SELL	$86.5 - $128.27 $4.38 Million - $6.5 Million	-50,680 Reduced 13.68%	319,917 $30.4 Million
Q1 2022 May 09, 2022	SELL	$101.96 - $128.34 $20.1 Million - $25.3 Million	-197,301 Reduced 34.74%	370,597 $43.6 Million
Q4 2021 Feb 04, 2022	BUY	$106.37 - $130.68 $29.6 Million - $36.4 Million	278,505 Added 96.24%	567,898 $73.6 Million
Q3 2021 Nov 08, 2021	BUY	$102.91 - $122.75 $1.69 Million - $2.02 Million	16,448 Added 6.03%	289,393 $32.8 Million
Q2 2021 Aug 13, 2021	BUY	$83.84 - $104.76 $22.9 Million - $28.6 Million	272,945 New	272,945 $28.3 Million

Others Institutions Holding EW

# of Institutions

1,458

Shares Held

468M

Call Options Held

3.46M

Put Options Held

4.07M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $53.4B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Toronto Dominion Bank, based on Form 13F filings with the SEC.

News

Stay updated on Toronto Dominion Bank with notifications on news.

Account

Toronto Dominion Bank Edwards Lifesciences Corp Transaction History